Accessibility statement

CHE Staff publications archive

Staff in CHE publish frequently, including contributing to journals, books and commissioned reports. Archived publications are listed by year.

2007 | 20082009 | 2010 2011 

2012

  • Allen P, Keen J, Wright J, Dempster PG, Townsend J, Hutchings A, Street AVerzulli R. Investigating the governance of autonomous public hospitals in England: multi-site case study of NHS Foundation Trusts. Journal of Health Services Research and Policy 2012;17(2):94-100. Download from Sage
  • Ashby R, Dumville J, Soares M, McGinnis E, Stubbs N, Torgerson D, Cullum N. A pilot randomised controlled trial of negative pressure wound therapy (NPWT) to treat grade III/IV pressure ulcers. Trials 2012;13(119). Download from trialsjournal
  • Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Medical Decision Making 2012;32(1):56-69.
  • Bojke L, Spackman E, Hinde S, Helliwell P. Capturing all of the costs in NICE appraisals: the impact of inflammatory rheumatic diseases on productivity. Rheumatology 2012;51(2):210-15.
  • Bower P, Kennedy A, Reeves D, Richardson G. A cluster randomised controlled trial of the clinical and cost-effectiveness of a “whole-systems” model of self management support for the management of long term conditions in primary care:trial protocol. Implementation Science 2012;7:7(January).
  • Briggs AH, Weinstein MC, Fenwick E, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: A report of the ISPOR-SMDM Modelling Good Research Practices Task Force Working Group-6. Medical Decision Making 2012;32(5):722-32.
  • Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD. on behalf of the ISPOR-SMDMK Modelling Good Research Practices Task Force (2012).  Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modelling Good Research Practices Task Force-6. Value in Health 2012;15(6):835-42.
  • Brown S, Ortiz-Nuñez A, Taylor K. Parental risk attitudes and children’s academic test scores: evidence from the U.S. panel study of income dynamics. Scottish Journal of Political Economy 2012;59(1):47-70.
  • Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children Aged 6-11 years: a NICE single technology appraisal. Pharmacoeconomics 2012;30(11):991-1004. Download from springer
  • Burch J, Hinde S, Palmer S, Beyer F, Minton J, Marson A, Wieshmann U, Woolacott N, Soares M. The clinical and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model. Health Technology Assessment 2012;16(34). Download from NIHR
  • Burch J, Marson A, Beyer F, Soares M, Hinde S, Wieshmann U, Woolacott N. Dilemmas in the interpretation of diagnostic accuracy studies on presurgical workup for epilepsy surgery. Epilepsia 2012;53(8):1294-302. Download from wiley 
  • Burton C, Richardson G, Sharpe M. Healthcare costs incurred by repeated referral of patients with medically unexplained symptoms to secondary medical care. Journal of Psychosomatic Research 2012;72(3):242-247.
  • Cabieses B, Espinoza M. The power of chameleonic ideas in the policy decision-making process: the case of the 'students' revolution' in Chile. Journal of Education for Teaching: International research and pedagogy 2012;38(4):509-11.
  • Chuang LH, Soares MO, Tilbrook H, Cox H, Hewitt CE, Aplin J, Semlyen A, Trewhela A, Watt I, Torgerson D. A pragmatic multi-centered randomised controlled trial of yoga for chronic low back pain: economic evaluation Spine 2012;37(18):1593-1601.
  • Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman DE, Youn J. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technology Assessment 2012;16(46). Download from NIHR
  • Conigliani C, Manca A, Tancredi A. Statistical methods for health care economic evaluation. In: Faltin F, Kenett R, Ruggeri F, editors. Statistical Methods in Healthcare:Wiley;2012:Chapter 18.
  • Cookson RClaxton KThe humble economist. Tony Culyer on health, health care and social decision making. Office of Health Economics, London and University of York, 2012. 
  • Cookson R, Dawson D. Hospital competition and patient choice in publicly funded health care. In: Jones AM, editor. The Elgar Companion to Health Economics (2 nd Edition) Cheltenham: Edward Elgar;2012.
  • Cookson R, Laudicella M, Li Donni P. Measuring change in health care equity using small area administrative data – evidence from the English NHS 2001-8. Social Science and Medicine 2012;75(8):1514-1522.
  • Cookson R, Laudicella M, Li Donni P, Dusheiko M. Effects of the Blair/Brown health reforms on socioeconomic equity in health care. Journal of Health Services Research and Policy 2012;17(Suppl1):55-63.
  • Cooper NJ, Kendrick D, Achana F, Dhiman P, He Z, Wynn P, Le Cozannet E, Saramago P, Sutton A. Network meta-analysis to evaluate the effectiveness of interventions to increase the uptake of smoke alarms. Epidemiologic Reviews 2012;34(1):32-45.
  • Costa-Font J, Karlsson M, Van den Berg B. Redesigning long-term care finance and delivery. Applied Economic Perspectives and Policy 2012;34(2):215-19.
  • Culyer AJ, Bombard Y. An equity framework for health technology assessments. Medical Decision Making 2012;32(3):428-441.
  • Culyer AJ. Hic sunt dracones: the future of Health Technology Assessment - one economist's perspective. Medical Decision Making 2012;32:E25-E32.
  • Daidone S, Street A. Specialisation hierarchy within the Children’s Specialised Services National Definition Set. Report to Department of Health, Economics of Social and Health Care Research Unit, University of York; 2012. Download from eshcru
  • Drummond MF. Economic evaluation and decision makers In: Jones AM, editor. The Elgar Companion to Health Economics. Cheltenham: Edward Elgar;2012:p.640.
  • Drummond M, Neumann P, Jonsson B, Luce B, Schwartz J, Siebert U, Sullivan S. Can we reliably benchmark health technology assessment organizations? International Journal of Technology Assessment in Health Care 2012;28(2):159-65.
  • Drummond MF, Towse A. Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe? European Journal of Health Economics 2012;13:1-5.
  • Dumville JC, Soares MO, O'Meara S, Cullum N. Systematic review and mixed treatment comparison: Dressings to heal diabetic foot ulcers. Diabetologia 2012;55(7):1902-1910. Download from springerlink
  • Faria R, Weatherly H, Van den Berg B. A review of approaches to measure and monetarily value informal careBerg. In: Curtis L, editor. Unit costs of health and social care 2012. Kent: PSSRU; 2012. p. 22-31
  • Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond MF, Jonsson B, Scambia G, Zweifel P, Mennini F. Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases. The BEST study. Medical Care 2012;50(12):1076-85.
  • Fleetcroft R, Steel N, Cookson R, Walker S, Howe A. Incentive payments are not related to expected health gain in the pay for performance scheme for UK primary care: cross-sectional analysis. BMC Health Services Research 2012;12(94). Download from biomedcentral
  • Ford JA, Waugh N, Sharma P, Sculpher MJ, Walker A. NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium. BMJ Open 2012;2(1):e000671. Download from bmjopen
  • Garber AM, Sculpher M. Cost-effectiveness and payment policy. In: Pauly MV, McGuire TG, Barros PP, editors. Handbook in Health Economics. Oxford: Elsevier; 2012.
  • Gaughan J, Kobel C, Linhart C, Mason AStreet A, Ward P. Why do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across ten European countries. Health Economics 2012;21(S2):77-88. Download from wiley
  • Howdon D. Time and chance happen to them all? duration modelling versus lifetime incidence of cancer. Health Economics and Data Group (HEDG), University of York 2012;working paper 12/06. Download from HEDG
  • Jones AM, Rice N, Bago d'Uva T, Balia S. Applied Health Economics (Second Edition). London: Routledge, 2012. 
  • Jones AM, Rice N, Contoyannis PC. The dynamics of health. In: Jones AM, editor. Elgar Companion to Health Economics (second Edition). Cheltenham: Edward Elgar; 2012.
  • Jones AM, Rice N, Robone S. A comparison of parametric and non-parametric adjustments using vignettes for self-reported data. Health Economics and Data Group (HEDG), University of York 2012;12/10. Download from HERC
  • Jones AM, Rice N, Rosa-Dias P. Quality of schooling and inequality of opportunity in health. Empirical Economics 2012;42(2):369-394.
  • Joyce VR, Barnett PG, Chow A, Bayoumi AM, Griffin S, Sun H, Holodniy M, Brown ST, Kyriakides TC, Cameron DW, Youle M, Sculpher M, Anis AH, Owens DK. Effect of treatment interruption and intensification of antiretroviral therapy on health related quality of life in patients with advanced HIV: a randomized, controlled trial. Medical Decision Making 2012;32(1):70-82. Download from sagepub
  • Kontopantelis E, Doran T, Gravelle H, Siciliani L, Sutton M, Goudie R. Pay-for-performance and influenza immunization: the impact of raising the bar in the UK Quality and Outcomes Framework. Health Services Research 2012;47(3, part 1):1117-36.
  • Laudicella M, Siciliani L, Cookson R. Waiting times and socioeconomic status: evidence from England. Social Science and Medicine 2012;74(9):1331-41.
  • Luce B, Drummond MF. Principles for the conduct of comparative effectiveness research. Journal of Comparative Effectiveness Research 2012;1(5):431-40.
  • Manca A, Asseburg C, Bravo-Vergel Y, Seymour MT, Meade A, Stephens R, Parmar M, Sculpher MJ. The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS). Value in Health 2012;15(1):22-31.
  • Martin R, Muûls M, de Pruex L, Wagner U. Anatomy of a paradox: management practices, organizational structure and energy efficiency. Journal of Environmental Economics and Management 2012;63(2):208-223.
  • Martin S, Rice N, Smith PC. Comparing costs and outcomes across programmes of healthcare. Health Economics 2012;21(3):316-337.
  • Mason A, Or Z, Renaud T, Street A, Thuilliez J, Ward P. How well do DRGs for appendectomy explain variations in resource use? An analysis of patient-level data from 10 European countries. Health Economics 2012;21(S2):30-40. Download from wiley
  • Maund E, Craig D, Suekarran S, Neilson AR, Wright K, Brealey S, Dennis L, Goodchild L, Hanchard N, Rangan A, Richardson G, Robertson J, McDaid C. Management of frozen shoulder: a systematic review and cost-effectiveness analysis. HTA Report 09/13/02 2012.
  • McKenna C, Maund E, Sarowar M, Fox D, Stevenson M, Pepper C, Woolacott N, Palmer S. Dronedarone for the treatment of atrial fibrillation. A NICE Single Technology Appraisal. Pharmacoeconomics 2012;30:35-46.
  • McKenna C, Wade R, Faria R, Yang H, Stirk L, Gummerson N, Sculpher M, Woolacott N. EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation. Health Technology Assessment 2012;16(14):1-188. Download from HTA
  • McKenna CWalker S, Lorgelly P, Fenwick E, Burch J, Suekarran S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Palmer S. Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure. Value in Health 2012;15(3). More details  from Value in Health
  • Miraldo M, Siciliani L, Street A. Price adjustment in the hospital sector, Reply. Journal of Health Economics 2012;31(1):323-25.
  • Mujica-Mota RE, Tarricone R, Ciani O, Bridges JFP, Drummond MF. Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Services Research 2012;12(1).
  • O'Reilly J, Busse R, Häkkinen U, Or Z, Street A, Wiley M. Paying for hospital care: the experience with implementing activity-based funding in five European countries. Health Economics Policy and Law 2012;7(1):73-101.
  • Pichon-Riviere A, Augustovski F, Marti SG, Sullivan SD, Drummond MF. Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers. International Journal of Technology Assessment in Health Care 2012;28(2):180-86.
  • Pitman RL, White LJ, Sculpher MJ. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine 2012;30:1208-24.
  • Revill P, Sculpher MJ. Cost effectiveness of interventions to tackle non-communicable diseases. British Medical Journal 2012;344:d7883. Download from bmj
  • Rodgers M, Asaria M, Walker S, McMillan D, Lucock M, Harden M, Palmer S, Eastwood A. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review. Health Technology Assessment 2012;16(28):1-129. Download from HTA
  • Rice NRobone S, Smith P. Vignettes and health systems responsiveness in cross-country comparative analyses. The Journal of the Royal Statistical Society A 2012;175(2):1-21.
  • Saramago PManca A, Sutton AJ. Deriving input parameters for cost-effectiveness modelling: taxonomy of data types and approaches to their statistical synthesis. Value in Health 2012;15(5):639-649.
  • Saramago P, Sutton A, Cooper NJ, Manca A. Mixed treatment comparisons using aggregate-and individual-participant level data statistics in medicine Statistics in Medicine 2012;doi:10.1002.sim.5442.
  • Schut FT, Van den Berg B. Long-term care insurance in the Netherlands. In: Costa-Font J, Courbage C, editors. Financing Long-Term Care in Europe: Palgrave; 2012.
  • Sculpher M, Claxton K. Real economics needs to reflect real decisions:A response to Johnson. PharmacoEconomics 2012; 30(2):133-136. Download from springer
  • Smith PC, Street A. Concepts and challenges in measuring the performance of health care organizations. In: Jones A, editor. Elgar Companion to Health Economics: Second Edition: Edward Elgar, Cheltenham; 2012. p.341-49.Further details
  • Smith PC, Street A. On the uses of routine patient-reported health outcome data. Health Economics 2012;22(2):119-131.
  • Soares MO. Is the QALY blind, deaf and dumb to equity? NICE's considerations over equity. British Medical Bulletin 2012;101(1):17-31. Download from oxfordjournals
  • Soares MO, Canto e Castro L. Continuous time simulation and discretized models for cost-effectiveness analysis. Pharmacoeconomics 2012;30(12):1101-17. Download from springer
  • Soares MO, Dumville J, Ashby R, Iglesias C, Bojke L, Adderley U, McGinnis E, Stubbs N, Torgerson D, Claxton K, Cullum N. Methods to assess cost effectiveness and value of further research when data are sparse: negative pressure wound therapy for severe pressure ulcers. Medical Decision Making 2012;doi:10.1177/0272989X12451058. Download from sagepub
  • Soares MO, Welton NJ, Harrison DA, Peura P, Hari MS, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Rowan KM. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technology Assessment 2012;16(7).
  • Sorenson C, Drummond MF. Socio-economic value of orthopedic devices: evidence and methodological challenges. Orthopedic Research and Reviews 2012;4:87-96.
  • Sorenson C, Drummond MF, Chalkidou K. Comparative effectiveness research: the NICE experience. Journal of Clinical Oncology 2012;30(34).
  • Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. Measuring alzheimer disease progression with transition probabilities: estimates from NACC-UDS. Current Alzheimer Research 2012;9(9):1050-58.
  • Street A, Kobel C, Renaud T, Thuilliez J. How well do Diagnosis Related Groups explain variations in costs or length of stay among patients and across hospitals? Methods for analysing routine patient data. Health Economics 2012;S21:6-18. Download from wiley
  • Thwaites G, Auckland C, Barlow G, Cunningham R, Davies G, Edgeworth J, Greig J, Hopkins S, Jeyaratnam D, Jenkins N, Llewelyn M, Meisner S, Nsutebu E, Planche T, Read RC, Scarborough M, Soares MO, Tilley R, Török ME, Williams J, Wilson P, Wyllie S, Walker AS. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial. Trials 2012;13:241. Download from trials journal
  • Towse A, Drummond MF, Sorenson C. Measuring value:pharmacoeconomics theory and practice. In: Danzon P, Nicholson S, editors. The Oxford Handbook of The Economics of the Biopharmaceutical Industry. Oxford: Oxford University Press; 2012. p.394-437.
  • Van den Berg B. SF-6D population norms. Health Economics 2012;21(12):1508-1512.
  • Wade R, Yang H, McKenna C, Faria R, Gummerson N, Woolacott N. A systematic review of the clinical effectiveness of EOS 2D/3D X-ray imaging system. European Spine Journal 2012;DOI 10.1007/s00586-012-2469-7.
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. Journal of Health Economics 2012;31:406-39.
  • Walker S, Griffin S, Claxton K, Palmer S, Sculpher M. Guest editorial, Appropriate perspectives for health care decisions. In: Curtis L, editor. Unit costs of health and social care 2012. Kent: PSSRU; 2012. p. 8-11. Download from pssru
  • Walker S, Sculpher M, Claxton K, Palmer S. Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions. Value in Health 2012;15(3)570-579. More details from Value in Health
  • Wang S, Chalkley M, Tilley C. Comparing the treatment provided by UK and non-UK trained health professionals: dentists in Scotland. Health Services Research & Policy 2012;17(4):227-232. Download from sage journals
  • Wasi N, Van den Berg B, Buchmueller T. Heterogeneous effects of child disability on maternal labor supply: evidence from the 2000 US census. Labour Economics 2012;19(1):139-154.
  • Yang H, Craig D, Epstein D, Bojke L, Light K, Bruce I, Sculpher M, Woolacott N. Golimumab for the treatment of psoriatic arthritis: A NICE Single Technology Appraisal. Pharmacoeconomics 2012;30:257-70.
  • Zucchelli E, Harris M, Zhao X. Ill-health and transitions to part-time work and self-employment among older workers. Health Economics and Data Group (HEDG), University of York 2012;working paper 12/04. Download from HERC
  • Zucchelli E, Jones AM, Rice N. The evaluation of health policies through dynamic microsimulation methods. International Journal of Microsimulation 2012;5(1):2-20.

2011

  • Asaria M, Norman G, Hinde S, O'Connor J, Palmer S, Light K, Soares M, Eastwood A. Fingolimod for the treatment of relapsing remitting multiple sclerosis. (PDF , 2,151kb). CRD/ CHE Technology Assessment Group, University of York, 2011.
  • Backhouse M, Wonder M, Hornby E, Kilburg A, Drummond MF, Mayer FK. Early dialogue between the developers of new technologies and pricing and reimbursement agencies. Value in Health 2011;14:608-15.
  • Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin S, Nosyk B, Holodniy M, Brown ST, Sculpher M, Anis AH, Owens DK. Determinants of the cost of health services used by veterans with HIV. Medical Care 2011;49(9):848-56.Download from pubmed
  • Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD. Review and meta-analysis of biomarkers and diagnostic imaging in alzheimer's disease. J Alzheimers Dis 2011;26(4).
  • Bloudek LM, Spackman DE, Veenstra DL, Sullivan SD. CDR state transition probabilities in alzheimer's disease with and without cholinesterase inhibitor intervention in an observation cohort J Alzheimers Dis 2011;24(3).
  • Bojke L, Epstein D, Craig D, Rodgers M, Woolacott N, Yang H, Sculpher M. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. Rheumatology 2011;50:iv39-iv47.
  • Brown S, Dietrich M, Ortiz-Nuñez A, Taylor K.  Self-employment and attitudes towards risk: timing and unobserved heterogeneity. Journal of Economic Psychology 2011;32:425-433.
  • Brown S, Ortiz-Nuñez A, Taylor K. What will I be when I grow up? an analysis of childhood expectations and career outcomes. Economics of Education Review 2011;30:493-506.
  • Burgess J, Street A. Measuring organisational performance. In: Smith PC, Glied SA, editors. The Oxford handbook of health economics. Oxford: Oxford University Press;2011.
  • Campbell HE, Epstein D, Bloomfield D, Griffin SManca A, Yarnold J, Bliss J, Johnson L, Earl H, Poole C, Hiller L, Dunn J, Hopwood P, Barrett-Lee P, Ellis P, Cameron D, Harris AL, Gray AM, Sculpher MJ. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer 2011;Nov 47(17):2517-30.Download from Sciencedirect
  • Carr-Hill R. A large-scale donor attempt to improve educational status of the poor and household income distribution; the experience of PEDC in Vietnam. International Journal of Educational Development 2011;31(3):251-61.
  • Castelli A, Laudicella M, Street AWard P. Getting out what we put in: productivity of the English NHS. Health Economics, Policy and Law 2011;6:313-335. Download from Cambridge Journals ©Cambridge Journals.
  • Chalkley M, Stewart G. Trade liberalisation, market structure and the incentive to merge. The World Economy 2011;34(8):1327-47.
  • Chase R, Culyer AJ, Dobrow M, Coyte P, Sawka C, O'Reilly S, Laing K, Trudeau M, Smith S, Hoch J, Morgan S, Peacok S, Abbott R, Sullivan T. Access to cancer drugs in Canada: looking beyond coverage decisions. Healthcare Policy 2011;6:27-35.
  • Chuang LH, Soares MO, Watson JM, Bland JM, Cullum N, Iglesias C, Kang'ombe AR, Torgerson D, Nelson EA, on behalf of the VenUS III team. Economic evaluation of a randomized controlled trial of ultrasound therapy for hard-to-heal venous leg ulcers. British Journal of Surgery 2011;98(8):1099-1106. Download from Wiley
  • Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health care technologies. Health Economics 2011;20(1):2-15. Download from Wiley
  • Cookson R. The tough test for the NHS isn’t cost but care. Parliamentary Brief 2011;13(6).
  • Cookson R, Laudicella M. Effects of Health Reform on Health Care Inequalities - Final ReportNIHR SDO Programme - London 2011.
  • Culyer AJ. Maximising the odds. New Statesman (supplement: Competition in a New Society: National Health) 2011;15 December 6-8.
  • Culyer AJUK report: NHS 'reforms: Health Care Cost Monitor 1-2, The Hastings Center; 2011.
  • Culyer AJ, Bombard Y. An equity framework for health technology assessments. Medical Decision Making 2012;32(3):428-441.
  • de Preux L. Anticipatory ex ante moral hazard and the effect of medicare on prevention. Health Economics 2011;20(9):1056-72.
  • Dixon J, Smith PC, Gravelle H, Martin S, Bardsley M, Rice N, Georghiou T, Dusheiko M, Billings J, De Lorenzo M, Sanderson C. A person based formula for allocating commissioning funds to general practices in England: development of a statistical model. British Medical Journal 2011;DOI: 10.1136/bmj.d6608.
  • Drummond MF, Augustovski F, Melendez G, Lemgruber A. Implementing pharmacoeconomic guidelines in Latin America: lessons learned. Value in Health 2011;14:S3-S7.
  • Drummond MF, Jönsson B, Rutten F, Stargardt T. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. The European Journal of Health Economics 2011;12:263-71.
  • Dusheiko M, Doran T, Gravelle H, Fullwood C, Roland M. Does higher quality of diabetes management in family practice reduce unplanned hospital admissions? Health Services Research 2011;46:27-46.
  • Dusheiko M, Gravelle H, Martin S, Rice N, Smith PC. Does disease management in primary care reduce hospital costs? Evidence from English primary care. Journal of Health Economics 2011;30(5):919-32.
  • Elston J, Santaniello-Newton A, Meigh J, Harmer D, Allgar V, Allison T, Richardson G, Meigh R, Palmer SR, Barlow G. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake- surveillance in Hull and East Yorkshire, United Kingdom, 2002-2009. Epidemiology and Infection 2011;DOI:10.1017/S0950268811001907.
  • Epstein D, Sutton A. Modelling correlated clinical outcomes in health technology appraisal. Value in Health 2011;14(6):793-99.Download from Value in Health
  • Felix J, Andreozzi V, Soares M, Borrego P, Gervasio H, Moreira A, Costa L, Marcelo F, Peralta F, Furtado I, Pina F, Albuquerque C, Santos A, Passos-Coelho JL. For the Portuguese group for the study of bone metastases. Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: An estimation for the Portuguese National Health System. Value in Health 2011;14(4).
  • Fleetcroft R, Cookson R, Steel N, Howe A. Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis. British Journal of General Practice 2011;61:554-55.
  • Garau M, Shah K, Mason A, Wang Q, Towse A, Drummond M. Using QALYs in cancer: a review of the methodological limitations. Pharmacoeconomics 2011;29(8):673-85.
  • Goudie R, Goddard M. Review of evidence on what drives economies of scope and scale in the provision of NHS services, focusing on A & E and associated hospital services. Report for the OHE Commission on Competition in the NHS. London: Office of Health Economics;2011. Download from OHE
  • Gravelle H, Hole AR, Santos R. Measuring and testing for gender discrimination in physician pay: English family doctors. Journal of Health Economics 2011;30(4):660-74.
  • Griffin S, Claxton K. Analysing uncertainty in cost-effectiveness for decision making. In: Glied S, Smith PC, editors. Oxford Handbook of Health Economics. Oxford: Oxford University Press; 2011.
  • Griffin S, Claxton K, Palmer S, Sculpher M. Dangerous omissions: the consequences of ignoring decision uncertainty. Health Economics 2011;20:212-24.
  • Harrison M, Bansback N, Marra C, Drummond MF, Tugwell B. Valuing health for clinical and economic decisions: directions relevant for rheumatologists. The Journal of Rheumatology 2011;38(8):1770-75.
  • Hassink WHJ, Van den Berg B. Time-bound opportunity costs of informal care: Consequences for access to professional care, caregiver support, and labour supply estimates. Social Science and Medicine. 2011;73(10):1508-16.
  • Hastrup LH, Van den Berg B, Gyrd-Hansen D. Do informal caregivers in mental illness feel more burdened? A comparative study of mental versus somatic illnesses. Scandinavian Journal of Public Health 2011;39:598-6-7.
  • Hawkins N, Richardson G, Sutton A, Cooper N, Griffiths C, Rogers A, Bower P. Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Economics 2011;DOI:10.1002/hec.1741.
  • Hvenegaard A, Nielsen Arendt J, Street A, Gyrd-Hansen D. Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments? European Journal of Health Economics 2011;12:541-51.
  • Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. The attitudes of primary school children in Northern Thailand towards their peers who are affected by HIV and AIDS. Aids Care 2011;23:237-44.
  • Jackson CH, Bokje L, Thompson SG, Claxton K, Sharples LD. A framework for addressing structural uncertainty in decision models. Medical Decision Making 2011;31(4):662-674.Download from sagepub
  • Jacobs R, Barrenho E. The impact of crisis resolution and home treatment teams on psychiatric admission rates in England. British Journal of Psychiatry 2011;199(1):71-76.
  • Jones AM, Lomas J, Rice N. Applying beta-type size distributions to healthcare cost regressions. Health Econometrics and Data Group (HEDG),University of York 2011;11/31Download from HERC  
  • Jones AM, Laporte A, Rice NZucchelli E. A model of the impact of smoking bans on smoking with evidence from bans in England and Scotland. Health Economics and Data Group (HEDG), University of York 2011;working paper 11/05.Download from HERC
  • Jones AM, Rice NRosa Dias P. Long-term effects of schooling quality on health and lifestyle: Evidence from comprehensive schooling reforms in England. Journal of Human Capital 2011;5(3):342-76.
  • Jones AM, Rice N, Robone SRosa-Dias P. Inequality and polarisation in health systems' responsiveness: a cross-country analysis. Journal of Health Economics 2011;30(4):616-25.
  • Kolosa K, Manca A, Schubert S. A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policy making processes in Poland. Health Policy 2011;102(2-3):145-151.
  • Longworth L, Sculpher MBokje L, Tosh J. Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. International Journal of Technology Assessment in Health Care 2011;27(2):180-7.Download from pubmed
  • Mandalà M, Imberti G, Piazzalunga D, Belfiglio M, Di Biagio K, Robone S, Labianca R, Marchesi L, Merelli B, Poletti P, Milesi A, Milesi L, Tondini C. Socio-economic status and education grade influence Breslow thickness, disease free and overall survival in clinical stage I-II AJCC skin melanoma: outcome analysis from a single institution experience. Mayo Clinic Proceedings 2011;16(2).
  • Marks L, Cave S, Wallace A, Mason A, Hunter DJ, Mason JM, Peckham S. Incentivising preventive services in primary care: perspectives on the use of Local Enhanced Services. Journal of Public Health 2011; 33 (4): 556-564.
  • Martin M, Lensberg B, Drummond MF, McGuire A. Relative efficacy - towards a new frontier? ISPOR Connections 2011;17(5):8-10.
  • Mason A, Goddard M, Myers L, Verzulli R. Navigating uncharted waters? How international experience can inform the funding of mental health care in England. Journal of Mental Health 2011;20(3);234-48. Download from informa.
  • Mason A, Ward P, Street A. England: the Healthcare Resource Group system. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England: Open University Press;2011;p197-220.
  • Mauskopf JA, Walter J, Copley-Merriman K, Birt J, Bowman LLB, Drummond MF. Differences among formulary submission guidelines:implications for health technology assessment. International Journal of Technology Assessment in Health Care 2011;27(3):261-70.
  • Maynard A, Street A, Hunter R. Using ‘payment by results’ to fund the treatment of dependent drug users-proceed with care! Addiction 2011;106(10):1715-1882.
  • McKenna C, Claxton K. Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis. Medical Decision Making 2011;31:853-865.Download from Pubmed
  • Miraldo M, Siciliani LStreet A. Price adjustment in the hospital sector. Journal of Health Economics;30(1):112-125.
  • Morris S, Goudie R, Sutton M, Gravelle H, Elliott R, Hole A, Ma A, Sibbald B, Skatun D. Determinants of general practitioners’ wages in England. Health Economics 2011;20:147-60.
  • Norman G, Rice S, Spackman E, Stirk L, Danso-Appiah A, Suh D, Palmer S, Eastwood A. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Health Technology Assessment 2011;15(Suppl 1):33-42.
  • Paulden M, Claxton K. Budget allocation and the revealed social rate of time preference for health. Health Economics 2011;21(5):612-618. Download from Wiley
  • Powdthavee N, van den Berg B. Putting different price tags on the same health condition: Re-evaluating the well-being valuation approach. Journal of Health Economics 2011;30(5):1032-43.
  • Rice N, Robone S, Smith PC. Analysis of the validity of the vignette approach to correct for heterogeneity in reporting health system responsiveness. The European Journal of Health Economics 2011;12(2):141-62.
  • Robone S, Jones AM, Rice N. Contractual conditions, working conditions, health and well-being in the British Household Panel Survey. The European Journal of Health Economics 2011;12(5):429-44.
  • Robone S, Rice N, Smith P. Health systems` responsiveness and its characteristics: a cross-country comparative analysis. Health Services Research 2011;46(6):2079-100.
  • Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technology Assessment 2011;15(10):1-329. Download from HTA
  • Rodgers M, Soares MEpstein D, Yang H, Fox D, Eastwood A. Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. Health Technology Assessment 2011;15:Suppl.1.Download from HTA
  • Rogers A, Vassilev I, Sanders C, Kirk S, Chew-Graham C, Kennedy A, Protheroe J, Bower P, Blickem C, Reeves D, Kapadia D, Brooks H, Fullwood C, Richardson G. Social networks, work and network-based resources for the management of long-term conditions: a framework and study protocol for developing self-care support. Implementation Science 2011;6:56(May).
  • Sampat B, Drummond MF. Another special relationship? interactions between health technology policies and health care systems in the United States and the United Kingdom. Journal of Health Politics, Policy and Law 2011;36:119-39.
  • Soares MOBojke L, Dumville J, Iglesias C, Callum N, Claxton K. Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration. Statistics in Medicine 2011;30(19):2363-2380. Download from Wiley
  • Sorenson C, Tarricone R, Siebert M, Drummond MF. Applying health economics for policy decision making: do devices differ from drugs? Europace Spotlight Supplement 2011;13:ii54-ii58.
  • Star SM, Van den Berg B. Individual responsibility and health-risk behaviour: A contingent valuation study from the ex ante societal perspective. Health Policy 2011;101:300-311.
  • Street A, O'Reilly J, Ward P, Mason A. DRG-based hospital payment and efficiency: theory, evidence, and challenges. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England:Open University Press;2011:p93-114.
  • Sullivan PW, Slejko JF, Sculpher MJ. Catalogue of EQ-5D Scores for the United Kingdom. Medical Decision Making 2011;31(6):800-804.
  • Tarricone R, Drummond MF. Challenges in the clinical and economic evaluation of medical devices:The case of transcatheter aortic valve implantation. Journal of Medical Marketing 2011;11(3):221-29.
  • Towse A, Drummond MF, Sorenson C. Measuring value:pharmacoeconomics theory and practice. London: Office of Health Economics; 2011.
  • Tso P, Culyer AJ, Brouwers M, Dobrow MJ. Developing a decision aid to guide public sector health policy decisions: A study protocol. Implementation Science 2011;6(46).
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. World Bank Policy Research Working Paper Series 2011;5829.
  • Walker S, Burch J, McKenna C, Wright K, Griffin S, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: Health Technology Assessment 2011;15:Suppl.1:13-21.
  • Walker S, Sculpher M, Drummond MF. The methods of cost-effectiveness analysis to inform decisions about the use of health care interventions and programmes. In: Smith PC, Glied S, editors. Oxford Handbook of Health Economics. Oxford: Oxford University Press; 2011. p. 733-58.
  • Watson JM, Kang'ombe AR, Soares MO, Chuang LH, Worthy G, Bland JM, Iglesias C, Cullum N, Torgerson D, Nelson EA on behalf of the VenUS III Team. Use of weekly,low dose, high frequency ultrasound for hard to heal venous leg ulcers: the VenUS III randomised controlled trial. BMJ 2011;342. Download from BMJ
  • Watson JM, Kang'ombe AR, Soares MO, Chuang LH, Worthy G, Bland JM, Iglesias C, Cullum N, Torgerson D, Nelson EA on behalf of the VenUS III team. A randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers. Health Technol Assess 2011;15(13):1-176. Download from HTA
  • Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, Palmer S, Busca R, Sculpher M. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2011;98:370-76.Download from BMJ
  • Weatherly H, Kirk S, Kyle RG, Callery P. Comparison of costs of acute care by children's community nursing teams Archives of Disease in Childhood 2011;96(Suppl 1):A92.

2010

  • Ashby R, Bland JM, Cullum N, Dumville J, Hall J, Kang'ombe A, Madden M, O'Meara S, Soares M, Torgerson D, Watson J. Reflections on the recommendations of the EWMA patient outcome group. Journal of Wound Care 2010;19(7):282-85. Download from Pubmed
  • Bailey H, Kind P. Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets. Quality of Life Research 2010;19(8):1145-54.
  • Barbieri M, Drummond M, Rutten F, Cook J, Glick H, Lis J, Reed SD, Sculpher M, Severens J. On behalf of the ISPOR good research practices economic data transferability task force. What do international pharmacoeconomic guidelines say about economic data transferability? Value in Health 2010;13:1028-37.
  • Bloudek L, Spackman DE, Sullivan SD. A comparison of transitions between health states and institutionalization among alzheimer's disease patients versus non-alzheimer's disease dementia patients using the nacc-uds database. Value in Health 2010;13(3):108-9.
  • Bojke L, Claxton K, Bravo Vergel Y, Sculpher M, Palmer S, Abrams K. Eliciting distributions to populate decision analytic models. Value in Health 2010;13(5):557-64. Download from Wiley interscience
  • Campbell JD, Spackman DE. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy 2010;65(9):1141-48.
  • Carr-Hill R. The poor may always be with us; but we don’t know how many there are or where they are. Journal of Health Services Research and Policy 2010;15:121-130.
  • Carr-Hill R, Roberts F, Currie E. Approaches to costing adult literacy programmes, especially in Africa. International Journal of Educational Development 2010;30:428-37.
  • Chambers D, Worthy G, Myers L, Weatherly H, Elliott R, Hawkins N, Sculpher M, Eastwood A. Glycopeptide versus non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surg Infect 2010;11(5):455-62.
  • Chuang LH, Kind P. The Effect of Health State Selection on the Valuation of EQ-5D. Medical Decision Making 2010;31(1):186-194.
  • Cookson R, Culyer AJ.  Measuring overall population health - the use and abuse of QALYs, in Killoran A, Kelly M (eds). Evidence based public health: effectiveness and efficiency, Oxford: Oxford University Press, 2010, 148-168.
  • Cookson R, Dusheiko M, Hardman G, Martin S. Competition and inequality: evidence from the English national health service 1991-2001. Journal of Public Administration Research and Theory 2010;20:181-205.
  • Cox H, Tilbrook H, Aplin J, Chuang LH, Hewitt C, Jayakody S, Semlyen A, Soares M, Torgerson DJ, Trewhela A, Watt I, Worthy G. A pragmatic multi-centred randomised controlled trial of yoga for chronic low back pain: trial protocol. Complementary Therapies for Clinical Practice 2010;16(2):76-80. Download from Elsevier
  • Culyer AJThe dictionary of health economics. 2nd Edition, Cheltenham: Edward Elgar, 2010.
  • Culyer AJ. Perspective and desire in comparative effectiveness research - the relative unimportance of mere preferences, the central importance of context. Pharmacoeconomics 2010;28:889-97.
  • Elliot RA, Weatherly HLAHawkins NS, Cranny G, Chambers D, Myers L, Eastwood A, Sculpher MJ. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? European Journal of Health Economics 2010;11(1):57-66. Download from springerlink
  • Fabbri D, Robone S. The geography of hospital admission in a National Health Service with patient choice: evidence from Italy. Health Economics 2010;19(9):1029-47.
  • Goddard MGravelle H, Hole A, Marini G. Where did all the GPs go? Increasing supply and geographical equity in England and Scotland. Journal of Health Services Research and Policy. 2010;15(1):28-35. Download from sage.
  • Gohel MS, Epstein D, Davies AH. Cost-effectiveness of traditional and endovenous treatments for varicose veins. Br J Surg 2010;97(12):1815-23. Download from pubmed
  • Gomes M, Soares MO, Dumville J, Lewis SC, Torgerson D, Bodenham A.R, Gough MJ, Warlow CP and the GALA collaborative group. Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial). British Journal of Surgery 2010;97(8):1218-1225. Download from BJS
  • Gravelle H, Sutton M, Ma A. Doctor behaviour under a pay for performance contract: treating, cheating and case finding? Economic Journal 2010;120:F129-F56.
  • Griffin SClaxton K, Welton N. Exploring the research decision space: the expected value of information for sequential research designs. Medical Decision Making 2010;30:155-62. Download from Sage journals
  • Gutacker N, Neumann A, Santosa F, Moysidis T, Kroeger K. Amputations in PAD patients - data from the German federal statistical office. Vascular Medicine 2010;15:9-14.
  • Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. Breaking down the wall of silence around children affected by AIDS in Thailand to support their psychosocial health. Aids Care 2010;22:308-13.
  • Kristensen T, Laudicella M, Ejersted C, Street A. Cost variation in diabetes care delivered in English hospitals. Diabetic Medicine 2010;27(8):949-57.
  • Jones AM, Rice N, Roberts J. Early retirement among men in Britain and Germany: how important is health? The Geneva papers on risk and insurance: issues and practice (Special issue on health and ageing) 2010;35:644-67.
  • Jones AM, Rice NRosa-Dias P. Quality of schooling and inequality of opportunity in health. Health, Econometrics and Data Group (HEDG), University of York 2010;10/22.
  • Jones AM, Rice NRosa-Dias P. Long-term effects of cognitive skills, social adjustment and schooling on health and lifestyle: Evidence from a reform of selective schooling. Health Economics and Data Group (HEDG), University of York Working Paper 2010;10/11.
  • Jones AM, Rice N, Robone S, Rosa-Dias P. Inequality and polarisation in health systems' responsiveness: a cross-country analysis. Health Economics and Data Group (HEDG), University of York working Paper 2010;10/27.
  • Laudicella M, Siciliani L, Cookson R. Waiting times and socioeconomic status: evidence from England. Health Econometrics and Data Group(HEDG), University of York 2010;10/05.
  • Laudicella M, Olsen KR, Street A. Examining cost variation across hospital departments - a two-stage multilevel approach using patient level data. Social Science and Medicine 2010;71(10):1872-1881.
  • Luce B, Drummond M, Jonsson B, Neumann PJ, Schwartz JS, Siebert U, Sullivan SD. (The International Working Group for HTA Advancement ) EBM, HTA and CER: clearing the confusion. The Millbank Quarterly 2010;88:256-76.
  • Manca A, Eldabe S, Buchser E, Kumar K, Taylor RS. Relationship between health related quality of life, pain and functional disability in neuropathic pain patients with failed back surgery syndrome. Value in Health. 2010;13(1):95-102.
  • Manca A, Sculpher M, Goeree R. The analysis of multinational cost effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics 2010;28:1079-96.
  • Marks L, Cave S, Hunter DJ, Mason JM, Peckham S, Wallace A, Mason AWeatherly H, Melvin K. Public health governance and primary care delivery: a triangulated study. final report; NIHR Service Delivery and Organisation programme 2010. 
  • Mason A, Drummond M, Ramsey S, Campbell J, Raisch D. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric? Journal of Clinical Oncology 2010;28(20):3234-38.
  • Mason AStreet AVerzulli R. Private sector treatment centres are treating less complex patients than the NHS. Journal of the Royal Society of Medicine 2010;103:322-31.
  • Maund E, McKenna C, Sarowar M. Dronedarone for the treatment of atrial fibrillation and atrial flutter. Health Technology Assessment 2010;14:Suppl.2. Download from pubmed
  • McCabe C, Chilcott J, Claxton K, Tappenden P, Cooper C, Roberts J, Cooper N, Abrams K. Continuing the multiple sclerosis risk sharing scheme is unjustified. British Medical Journal 2010;340(C1786) Download from BMJ
  • McKenna C , Burch J, Suekarran S. Aldosterone antagonists for post-myocardial infarction heart failure. Health Technology Assessment 2010;14(24):161.
  • McKenna C, Chalabi Z, Epstein DClaxton K. Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions. Journal of Health Economics 2010;29(1):170–181. Download from Science Direct
  • McKenna CHawkins NClaxton K, McDaid C, Suekarran S, Light K, Chester M, Cleland J, Woolacott N, Sculpher M. Cost-effectiveness of Enhanced External Counterpulsation (EECP) for the treatment of stable angina in the UK. International Journal of Technology Assessment in Health Care 2010;26(2):175-82. Download from Pubmed
  • McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer disease severity. Alzheimer's & Dementia 2010;6(6):482-03.
  • Neumann PJ, Drummond MF, Jonsson B, Luce BR, Schwartz JS, Siebert U, Sullivan S. Are key principles for improved health technology assessment supported and used by health technology assessment organizations? International Journal of Technology Assessment in Health Care 2010;26:71-78.
  • Norman G, Soares M, Peura P, Rice S, Suh D, Wright K, Sculpher M, Eastwood A. Capecitabin for advanced gastric cancer. Health Technology Assessment 2010;14(s2). Download from  Pubmed
  • Paton F, Paulden M, Saramago P, Manca A, Misso K, Palmer S, Eastwood A. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. Health Technology Assessment, 2010;14(S1):55-62.
  • Pattenden J, Mason ABetter Together: An end of life initiative for patients with heart failure and their families. M123S: Executive summary. British Heart Foundation, London. June 2010. Download from BHF
  • Pattenden J, Mason ABetter Together: An end of life initiative for patients with heart failure and their families. M123R: Final Report. British Heart Foundation, London. June 2010. Download from BHF
  • Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M. Alitretinoin for the treatment of severe chronic hand eczema. Health Technology Assessment 2010;14(s1):39-46. Download from NIHR
  • Pichon-Riviere A, Augustovski F, Rubinstein A, Marti SG, Sullivan SD, Drummond M. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? International Journal of Technology Assessment in Health Care2010;26:421-27.
  • Pridmore P, Carr-Hill R. Tackling the drivers of child undernutrition in developing countries: what works and how should interventions be designed? Public Health Nutrition 2010;19:1-6.
  • RESPECT Trial Team. Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. British Journal of General Practice. 2010;60:21-27.
  • Rice N, Robone S, Smith PC. International comparison of public sector performance: the use of anchoring vignettes to adjust self-reported data. Evaluation 2010;16:81-101.
  • Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram JR, Wollacott N, Sculpher M. Alitretinoin for severe chronic hand eczema: A NICE single technology appraisal. Pharmacoeconomics 2010;28(5):351-62. Download from Pubmed
  • Scheller-Kreinsen D, Geissler EA, Street A, Busse R. Leistungsbewertung von deutschen krankenhäusern - stärken, schwächen und vergleichbarkeit der bekannten methoden. Gesundh ökon Qual manag 2010;15:1-11.
  • Schut FT, Van den Berg B. Sustainability of comprehensive universal long-term care insurance in the Netherlands. Social Policy and Administration 2010;44:411-35.
  • Sculpher M, Claxton K. Sins of omission and obfuscation: IQWiG’s guidelines on economic evaluation methods. Health Economics 2010;19(10):1132-36.
  • Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C, Drummond MF. Evidence synthesis, economics and public policy. Research Synthesis Methods 2010;1:126-135.
  • Spilsbury K, Adamson J, Atkin K, Bloor K, Carr-Hill R, McCaughan D, McKenna H, Wakefield A. Challenges and opportunities associated with the introduction and development of assistant practitioners supporting the work of ward-based registered nurses in acute NHS trusts in England. Journal of Health Services Research and Policy 2010;Supplement.
  • Spilsbury K, Bloor K, Bartlett C, Bonsanquet K, Carr-Hill R. Assistant practitioners: identity, responsibilities and development. British Journal of Healthcare Assistants 2010;4:599-602.
  • Street A. Letter in response to articles on Choice and Competition. Health Economics, Policy and Law 2010;5(2):247.
  • Street A, Scheller-Kreinsen D, Geissler A, Busse R. Determinants of hospital costs and performance variation: methods, models and variables for the EuroDRG project. Working Papers in Health Policy and Management 2010;Vol.3 May:Berlin: Universitätsverlag der TU Berlin. Download from eurodrg
  • The United Kingdom EVAR trial investigators. Endovascular versus open repair of abdominal aortic aneurysm. New England Journal of Medicine 2010;362:1863-71. Download from NEJM
  • The United Kingdom EVAR trial investigators. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. New England Journal of Medicine 2010;362:1872-80. Download from NEJM
  • Vitikainen K, Linna M, Street A. Substituting inpatient for outpatient care: what is the impact on hospital costs and efficiency? European Journal of Health Economics 2010;11(4):395-404. Download from springerlink
  • Wailoo AJ, Goodacre S, Sampson F, Hernandez M, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder MA, Gray H. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty Project. Heart 2010;96:668-72.
  • Walker SMason AClaxton KCookson R, Fenwick E, Fleetcroft R, Sculpher M. Value for money and the quality and outcomes framework in primary care in the NHS. British Journal of General Practice 2010;60(574):352-57. Download from BJGP
  • Walker D, Teerawattanonon Y, Anderson R, Richardson G. Generalisability, transferability, complexity and relevance. In: Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C, editors. Evidence-based decisions and economics: health care, social welfare, education and criminal justice, 2nd Edition: Wiley-Blackwell; 2010.
  • Wearden AJ, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Riste L, Richardson G, Lovell K, Dunn G. A randomised controlled trial of a nurse-led home-based self-help treatment for patients in primary care with chronic fatigue syndrome - the FINE trail. BMJ 2010;340:C1777.
  • Weatherly HMason A, Goddard M, Wright K. Financial integration across health & social care: evidence review. Scottish Government Social Research; 2010.

2009

  • Augustovski F, Iglesias CManca A, Drummond M, Rubinstein A, Garcia Marti S. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics 2009;27(11):919-29.
  • Austin PC, Manca A, Zwarenstein M, Juurlink DN, Stanbrook MB. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. Journal of Clinical Epidemiology, 2009;63(2):142-153.
  • Barbieri M, Hawkins NSculpher MJ. Who does the numbers? The role of third-party technology assessments to inform health systems' decision-making about the funding of health technologies. Value in Health. 2009;12:193-201.
  • Bojke L, Claxton K, Sculpher M, Palmer S . Characterizing structural uncertainty in decision-analytic models: a review and application of methods. Value in Health. 2009;12:739-49.
  • Bowyer S, Caraher M, Elbert K, Carr-Hill R. Shopping for food: lessons from a London borough. British Food Journal 2009;11:453-73.
  • Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(9):537-45.
  • Burch J, Epstein D, Baba-Akbari Sari A, Weatherly H, Jayne D, Fox D et al. Stapled haemorrhoidopexy for the treatment of haemorrhoids: a systematic review. Colorectal Disease. 2009;11:233-44.
  • Burch J, McKenna C, Palmer S, Norman G, Glanville J, Sculpher M, Woolacott N. Rimonabant for the treatment of overwieght and obese people. Health Technology Assessment 2009:13(Suppl3);3. Download from HTA
  • Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton N, Ades AE, Sutton A, Cooper N, Elliot A, Nicholson K, Duffy S, McKenna C, Stewart L, Westwood M, Palmer S. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess. 2009;13(58):1-290. Download from HTA
  • Carr-Hill R . Data monitoring and evaluation, annex F. mid-term evaluation of the EFA fast track initiative 2009.
  • Carr-Hill R , Mason A, Street ANICE Guidance on Cost Effectiveness of Community Engagement to Improve Health; 2009.
  • Castelli A, Jacobs R, Goddard M, Smith P . Geographical variation in quality of life: The role of public service organisations. Policy Briefing, Centre for Health Economics, University of York; 2009.
  • Castelli A, Jacobs R, Goddard M. Exploring the impact of public services on quality of life indicators: Public Services Programme: Quality, Performance & Delivery, Discussion Paper DP0902 2009.
  • Castelli A, Laudicella M, Street A, Ward P. Getting out what we put in (PDF , 224kb)‎ how productive is the NHS in England? Paper presented at the Health Economic Study Group Meeting. Sheffield 22-24 July 2009.
  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. The challenges of developing cost-effective public health guidance: a NICE perspective. In: Dawson S, Morris ZS, editors. Future public health: burdens, challenges and opportunities. Basingstoke: Palgrave Macmillan; 2009. p.276-91.
  • Chambers D, Epstein D, Walker S, Fayter D, Paton F, Wright K, et al. Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model. Health Technology Assessment 2009;13(48).
  • Chuang LH, Zarate V, Kind P. Estimating domestic values for EQ-5D health states using survey data from external sources. Medical Care 2009;47(2):168-75.
  • Conti S, Claxton K . Dimensions of design space: a decision theoretic approach to optimal research portfolio design. Medical Decision Making 2009;29:643-60. Download from Sage Journals online
  • Cooke D, Hurel SJ, Casbard A, Steed L, Walker S, Meredith S, Nunn AJ, Manca ASculpher M et al. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin-treated diabetes (MITRE Study). Diabetic Medicine 2009;26(5):540-7. Download from Wiley InterScience
  • Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Economics Policy and Law. 2009;4(2):231-45.
  • Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Reply to Richardson and Shiell. Health Economics Policy and Law.2009;4(2):261-263.
  • Cookson R, Laudicella MDo the poor still cost more? The relationship between small area income deprivation and length of stay for elective hip replacement in the English NHS from 2001/2 to 2006/7. Health Economics and Data Group (HEDG), University of York Working Paper 09/07 2009.
  • Culyer AJHealth, distribution and fairness - sorting out the theory and matching it to future policy practice (notes for the Select Committee on Health) House of Commons Select Committee on Health, 3rd Report:Health Inequalities;2009.
  • Culyer AJDeliberative processes in decisions about health care technologies: combining different types of evidence, values, algorithms and people. London: Office of Health Economics; 2009.
  • Culyer AJ. How nice is NICE? A conversation with Anthony Culyer, Health Care Cost Monitor, 2009 Hastings Centre Blog.
  • Dixon J, Asaria P, Georghiou T, Billings J, Gravelle H, Martin S, Rice N, Smith P, Wennberg D, DeLorenzo M, Siegal M, Russell R, Filipova N. Developing a person based resource allocation formula for general practices in England. Report to the Department of Health; October 2009.
  • Dobrow MJ, Chafe R, Burchett HED, Culyer AJ, Lemieux-Charles L. Designing deliberative methods for combining heterogeneous evidence: A systematic review and qualitative scan. A report to the Canadian Health Services Research Foundation. Ottawa; 2009.
  • Drummond M , Barbieri M, Cook J, Glick H, Lis J, Malik F, Reed S, Rutten F, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR Good Practices Task Force report. Value in Health. 2009;12:409-18.
  • Drummond M, Brixner D, Gold M, Kind P, McGuire A, Nord E. Consensus Development Group (2009) Toward a consensus on the QALY. Value in Health 2009;12(Suppl1):S31-35.
  • Dumville JC, Soares M. The economics of clinical decision making. In: Essential Decision Making and Clinical Judgement for Nurses. London: Churchill Livingstone; 2009.
  • Dumville JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, Mitchell JL, Nelson EA, Soares M, Torgerson DJ. VenUS II team. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. British Medical Journal 2009;Mar 19:338:b773. Download from BMJ
  • Dumville JC, Worthy G, Soares M, Bland JM, Cullum N, Dowson C, Iglesias C, McCaughan D, Mitchell JL, Nelson EA, Torgerson DJ. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers: Health Technology Assessment 2009 Nov;13(55):1-182, i-iv. Download from HTA
  • Elliot RA, Weatherly HLAHawkins NS, Cranny G, Chambers D, Myers L, Eastwood A, Sculpher MJ. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? European Journal of Health Economics 2009;11(1):57-66. Download from springerlink
  • Epstein D. Is EVAR worth the price difference? In: Greenhalgh R, editor. Vascular and Endovascular Controversies Update 31. London:Biba Medical;2009.
  • Epstein D. Opportunity Cost. In: Encyclopedia of Medical Decision Making. Sage Publications; 2009.
  • Epstein D, Bojke L, Sculpher M & the REFLUX trial group. The cost-effectiveness of laparoscopic fundoplication versus medical management for gastro oesophageal reflux disease. British Medical Journal 2009;338:b2576.
  • Epstein D, Jimenez Rubio D, Smith PC, Suhrcke M. Social determinants of health: an economic perspective. Health Economics 2009;18:495-502.
  • Gauthier A, Manca A, Anton S. Bayesian modelling of healthcare resource use in multinational randomised clinical trials. Pharmacoeconomics 2009;27(12):1017-1029.
  • Goddard M, Jacobs R. Using composite indicators to measure performance in health care. In: Smith PC, Mossialos E, Leatherman S, Papanicolas I, editors. Performance Measurement for Health System Improvement: experiences, challenges and prospects. Cambridge:Cambridge University Press;2009.Chapter 3.4. 
  • Goddard M, Mason A. Mental health learning points (PDF , 63kb)Healthcare Finance 2009 (November);pp39,41.
  • Gravelle H, Sutton M. Income, relative income, and self-reported health in Britain 1979-2000. Health Economics 2009;18(2):125-45.
  • Gravelle H, Sivey P. Imperfect quality information in a quality-competitive hospital market. Department of Economics and Related Studies (DERS), University of York Discussion Paper 2009;09/09.
  • Greenwood JP, Maredia N, Radjenovic A, Brown JM, Nixon J, Farrin AJ, Dickinson C, Younger JF, Ridgeway JP, Sculpher M, Ball SG, Plain S. Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study. Trials 2009;10:p62 (doi:10.1186/745-6215-10-62).
  • Griffin S , Dunn G, Palmer S, Macfarlane S, Brent S, Dyker A, et al. The use of paclitaxel in the management of early stage breast cancer. Health Technology Assessment 2009;13(s1):15-22.
  • Griffin S, Rice N, Sculpher M. Economic evaluation of public health interventions. In: Killoran A, Kelly M, editors. Evidence-based public health: effectiveness and efficiency. Oxford:Oxford University Press;2009.
  • Griffin S, Walker S, Sculpher M, et al. Cetuximab plus radiotherapy for the treatment of locally advance squamous cell carcinmoa of the head and neck. Health Technology Assessment 2009;13(s1):49-54. Download from HTA
  • Hann M, Goudie R, Sutton M, Gravelle H, Sibbald B. The Fifth National GP Worklife Survey. Final Report to Department of Health; June 2009.
  • Hewitt C, Gilbody S, Brealey S, Paulden M, Palmer S, Mann R, Green J, Morrell J, Barkham M, Light K, Richards D. Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technology Assessment 2009;13(36):1-145,47-230. Download from HTA
  • Hoomans T, Fenwick E, Palmer S, Claxton K. Value of information and value of implementation: application of a framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer. Value in Health 2009;12:315-24. Download from wiley InterScience
  • Hvenegaard A, Street A, Sørensen TH, Gyrd-Hansen D. Comparing hospital costs: what is gained by accounting for more than a case-mix index? Social Science & Medicine 2009;69:640-47.
  • Iglesias CManca A, Torgerson D. The health related quality of life and cost implications of falls in elderly women. Osteoporosis International 2009;Jun20(6):869-78.
  • Jacobs R. Which services improve our quality of life? Britain in 2010 magazine 2009:39.
  • Jacobs R, Castelli A, Goddard M, Smith PC. Impact of public services on quality of life indicators? LariaNews, LARIA Newsletter, Local Authorities Research Intelligence Association 2009.
  • Jacobs R, Chaloupka F, Tauras J, Water H. Taxation and the economics of tobacco control. In: Samet JM, Yoon SY, editors. Women and the Tobacco Epidemic: Challenges for the 21st century. Geneva: WHO; 2009.
  • Jacobs R, Street AFinal report: Efficiency analysis of PFI schemes: Report for the National Audit Office, November, pp34;2009.
  • Jacobs R, Street AThe relative efficiency of services delivered through hospital PFI contracts: feasibility study, Report for the National Audit Office York, Centre for Health Economics:14pp;2009.
  • Laudicella M, Cookson R, Jones AM, Rice N. Health care deprivation profiles in the measurement of inequality and inequity: an application to GP fundholding in the English NHS. Journal of Health Economics 2009;28(6):1048-61. Download from Sciencedirect
  • Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, Kind P, Kweon SS, Kim YT. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value in Health 2009;12(8):1187-93.
  • Manca A. Economic evaluation of medical devices and drugs - same or different? (Editorial). Value in Health 2009;12(4):401.
  • Manca A. Task force report on good research practices on economic data transferability in HTA (Editorial). Value in Health 2009;12(4):407.
  • Mannion R, Harrison S, Jacobs R, Konteh F, Walsh K, Davies HTO. From cultural cohesion to rules and competition: the trajectory of senior management culture in English NHS hospitals, 2001-2008. Journal of the Royal Society of Medicine 2009;102:332-36.
  • Mannion R, Street A. Managing activity and expenditure in the new NHS market: evidence from South Yorkshire. Public Money and Management 2009;29(1):27-34. Download from Taylor and Francis
  • Marini G, Miraldo M. Economies of scale and scope in the English hospital sector. Imperial College Business School Discussion Papers, 2009/05.
  • Martin S, Dusheiko M, Gravelle H, Rice N. Estimating needs for programme budget areas. Report to the Department of Health; December 2009.
  • McDaid C, Duree KH, Griffin SC, Weatherly HLA, Stradling JR, Davies RJO, Sculpher MJ, Westwood ME. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Medicine Reviews 2009;13(6):427-36. Details from Sleep Medicine Reviews 
  • McDaid C, Griffin S, Weatherly H, Duree KH, Burgt van der M, Hout van S, Akers J, Davies RJO, Sculpher M, Westwood M. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technology Assessment. 2009;13(4)pp1-142.
  • McKenna C, Bojke L, Manca A, et al. Shoulder acute pain in primary healthcare: Is retraining GP's effective (SAPPHIRE) randomised trial - cost effectiveness analysis. Rheumatology 2009;48:558-563.
  • McKenna C, McDaid C, Suekarran S, Hawkins NClaxton K, Light K, Chester M, Cleland J, Woolacott N, Sculpher M. Enhanced external counterpulsation (EECP) for the treatment of stable angina and heart failure: A systematic review and economic analysis. Health Technology Assessment 2009;13(24):1-112. Download from HTA
  • McKenna C, Palmer S , Rodgers M, et al. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the UK. Heart 2009;95:542-9. Download from BMJ
  • Mason A, Street A, Miraldo M, Siciliani L. Should prospective payments be differentiated for public and private healthcare providers? Health Economics, Policy and Law. 2009;4(4):383-403. Download from Cambridge journals.
  • Newman SP, Cooke D, Casbard A, Walker S, Meredith S, Nunn A, Steed L, Manca ASculpher M, et al. A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technology Assessment. 2009;May;13(28):iii-iv, ix-xi,1-194.
  • Pridmore P, Carr-Hill RAddressing the underlying and basic causes of child undernutrition in developing countries: what works and why?” for DANIDA;2009.
  • Richardson G, Bloor K, Williams J, Russell I, Durai D, Cheung W-Y, et al. Cost-effectiveness of nurse-delivered endoscopy: findings from a randomised multi-institution nurse endoscopy trial (MINuET) BMJ 2009;338:b270.
  • Richardson G, Bojke C, Kennedy A, Reeves D, Bower P, Lee V et al. What outcomes are important to patients with long term conditions? A discrete choice experiment. Value in Health 2009;12(2):331-9.
  • Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis. Health Technology Assessment. 2009;13(31):1-77. Download from HTA
  • Santana P, Santos R, Nogueira H. The link between local environment and obesity: a multilevel analysis in the Lisbon Metropolitan Area, Portugal. Social Science & Medicine 2009;68(4):601–609.
  • Sculpher MJ, Lozano-Ortaga G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, et al. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. American Heart Journal 2009;157:845-52.
  • Siciliani L. Paying for performance and motivation crowding out. Economics Letters 2009;103:68-71.
  • Siciliani LGravelle H. Third degree waiting time discrimination: optimal allocation of a public sector healthcare treatment under rationing by waiting. Health Economics. 2009;18:977-86.
  • Siciliani L, Stanciole A, Jacobs R. Do waiting times reduce hospitals' costs? Journal of Health Economics 2009;28(4):771-80.
  • Siciliani LVerzulli R. Waiting times and socioeconomic status among elderly Europeans: evidence from SHARE. Health Economics 2009;18(11):1295-306.
  • Soares M, Iglesias CP , Bland JM, Cullum N, Dumville JC, Nelson EA, Torgerson DJ, Worthy G. VenUS II team. Cost effectiveness analysis of larval therapy for leg ulcers British Medical Journal 2009 Mar;19:338:b825 doi:10.1136/bmj.b825. Download from BMJ
  • Smith PCGoddard M. The English National Health Service: an economic health check. Report for Organisation for Economic Co-operation and Development ECO/WKP58 July; 2009.
  • Spilsbury K, Stuttard L, Adamson J, Atkin K, Borglin G, McCaughan D, McKenna H, Wakefield A, Carr-Hill R. Mapping the introduction of assistant practitioner roles in acute NHS (hospital) trusts in England. Journal of Nursing Management 2009;17:615-26.
  • Street A, Hakkinen U. Health system productivity and efficiency. In: Smith PC, Mossialos E, Leatherman S, Papanicolas IN, editors. Performance measurement for health system improvement: experiences, challenges and prospects. World Health Organisation; 2009.
  • Street A, Laudicella MIdentifying inefficiency (PDF , 415kb): Why do costs differ from one hospital to another? Policy Briefing, Centre for Health Economics, University of York; 2009.
  • Taylor RS, Iglesias CP. Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different? Value in Health 2009;Jun 12(4):404-6.
  • Vallejo-Torres L, Morris S, Carr-Hill R, Dixon P, Law M, Rice N, Sutton M. Can regional resource shares be based only on prevalence data? an empirical investigation of the proportionality assumption. Social Science Medicine 2009;69:1634-42.
  • Vitikainen KStreet A, Linna M. Estimation of hospital efficiency - do different definitions and casemix measures for hospital output affect the results? Health Policy 2009;89:149-59.
  • Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane S, White S, Thomas S. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia. Health Technology Assessment 2009;13(sl):35-40. Download from HTA
  • Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Sculpher M, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy 2009;93:85-92. Download from Elsevier 
  • Weatherly HLA, Griffin S, McDaid C, Duree KH, Davies RJO, Stradling JR, Sculpher MJ et al. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome. International Journal of Technology Assessment in Health Care. 2009;25(01):26-34.
  • Williams J, Russell I, Durai D, Cheung W-Y, Farrin A, Bloor K, Coulton S, Richardson G. Effectiveness of nurse-delivered endoscopy: findings from a randomised multi-institution nurse endoscopy trial (MINuET) British Medical Journal. 2009;338:b231.

2008

  • Al-Ruzzeh S, Epstein D, George S, Bustami M, Wray J, Ilsley C, Sculpher M, Amrani M. Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial. Artificial Organs 2008;32(11):891-7. Download from Wiley InterScience
  • Bansback N, Sun H, Guh D, Li X, Nosyk B, Griffin S et al. The impact of using a recall period on the measurement of health utilities for acute events. Health Economics 2008;17(12):1413-1419.
  • Bojke L, Claxton K, Sculpher M, Palmer S, Philips Z. The cost-effectiveness and value for information associated with repeat screening for age related macular degeneration. Medical Decision Making 2008;28:33-43. Download from Sage Journals Online
  • Bravo Vergel Y, Sculpher M. Quality-adjusted life years. Practical Neurology 2008;8:175-82. Download from BMJ
  • Brouwer WBF, Culyer AJ, Job N, van Exel A, Rutten FFH. Welfarism vs. extra-welfarism. Journal of Health Economics 2008;27:325-38.
  • Burch J, Epstein D, Baba-Akbari A, Weatherly H, Fox D, Golder S, Jayne D, Drummond M, Woolacott N. Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. Health Technology Assessment 2008;12(8). Download from HTA
  • Chalabi Z, Epstein D, McKenna C, Claxton K. Uncertainty and value of information when allocating resources within and between healthcare programmes. European Journal of Operational Research 2008;191(2):530-9. Download from Science Direct
  • Chalkidou K, Culyer AJ, Littlejohns P, Doyle P, Hoy A. Imbalances in funding for clinical and public health research in the UK: can NICE research recommendations make a difference? Evidence and Policy 2008;4:355-69.
  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. Cost-effective public health guidance: asking questions from the decision-maker's viewpoint. Health Economics 2008;17:441-8.
  • Chalkidou K, Walley T, Culyer AJ, Littlejohns P, Hoy A. Evidence-informed evidence making. Journal of Health Services Research and Policy 2008;13:167-73.
  • Chauhan D, Mason A. Factors affecting the uptake of new medicines in secondary care - a literature review. Journal of Clinical Pharmacy and Therapeutics 2008;33(4):339-48.
  • Cheraghi-Sohi S, Hole A, Mead N, McDonald R, Whalley D, Bower P, et al. What do patients want from a primary care consultation: A stated preference discrete choice experiment to identify patient priorities. Annals of Family Medicine 2008;6(107-115).
  • Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008;9:781-98.
  • Claxton K, Briggs A, Buxton M, Culyer A, McCabe C, Walker SSculpher M. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ 2008;336:251-4. Download from BMJ
  • Claxton K, Culyer A. Not a NICE fallacy: A reply to Dr Quigley. Journal of Medical Ethics 2008;34:598-601. 
  • Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.  A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.  Health Technology Assessment 2008;12:1-168.
  • Culyer AJ, Amick B, LaPorte A. What is a little more health and safety worth? In:Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford:Oxford University Press 2008:15-35.
  • Culyer AJ, Tompa E. Equity. In:Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:215-31.
  • Culyer A, Sculpher M. Lessons from health technology assessment. In:Tompa E, Culyer A, Dolinschi R, eds. Economic Evaluation of Interventions for Occupational Health and Safety. Oxford:Oxford University Press 2008.
  • Doran T, Fullwood C, Gravelle H, Reeves D, Roland M. Should physicians be allowed to exclude individual patients from pay for performance targets? Analysis of exception reporting in the UK pay for performance scheme. New England Journal of Medicine. 2008;359;274-284.
  • Drummond M, Iglesias C, Cooper NJ. Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellance in the United Kingdom: A game of two halves? International Journal of Technology Assessment in Health Care 2008;24:146-50. Download from Cambridge Journals
  • Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ. Key principles for the improved conduct of health technology assessments for resource allocation decisions. International Journal of Technology Assessment in Health Care 2008;24(3):244-58.
  • Drummond M, Weatherly H, Ferguson B. Economic evaluation of health interventions: a broader perspective is needed that include potential cost and benefits for all stakeholders. British Medical Journal 2008;337:a1204.
  • Dusheiko M, Goddard M, Gravelle H, Jacobs R. Explaining trends in concentration of health care commissioning in the English NHS. Health Economics 2008;17(8):907-26. Download from Wiley Inter Science
  • Epstein DM, Garcia Mochon L. The accuracy of telemedicine compared with conventional methods in the diagnosis of malignant melanoma of the skin. Revista Espanola de Economia de la Salud 2008;7:193-6.
  • Epstein D, Sculpher M, Clayton T, Henderson R, Pocock SJ, Buxton M, et al. Costs of an early intervention versus a conservative strategy in acute coronary syndrome. International Journal of Cardiology 2008;127(2):240-6. Download from ScienceDirect
  • Epstein D, Sculpher M, Manca A, Michaels J, Thompson SG, Brown LC, et al. Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. British Journal of Surgery 2008;95:183-90.
  • Epstein D, Mason A, Manca A. The hospital costs of care for stroke in nine European countries. Health Economics 2008;17 (S1):S21-S31. Download from Wiley inter science
  • Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development. Medical Decision Making 2008;28:21-32. Download from Sage Journals Online
  • Golder S, Mason A, Spilsbury K. Systematic searches for the effectiveness of respite care. Journal of the Medical Library Association 2008;96(2):147-52.
  • Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M , et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technology Assessment 2008;12(31):1-204.
  • Gravelle H, Morris S, Sutton M. Are family physicians good for your health? Endogenous supply and health. Health Services Research 2008;43(4):1128-1144.
  • Gravelle H, Siciliani L. Optimal quality, waits and charges in health insurance. Journal of Health Economics 2008;27(3):663-74.
  • Gravelle HSiciliani L. Is waiting-time prioritisation welfare improving? Health Economics 2008;17:167-85.
  • Gravelle H, Siciliani L. Ramsey waits: allocating public health service resources when there is rationing by waiting. Journal of Health Economics 2008;27(5):1143-54.
  • Griffin S, Claxton K, Sculpher M. Decision analysis for resource allocation in health care. Journal of Health Services Research and Policy 2008;13:23-30. Download from RSM Press
  • Griffin S, Weatherly H, Richardson G, Drummond M. Methodological issues in undertaking independant cost-effectiveness analysis for NICE: the case of therapies for ADHD. The European Journal of Health Economics 2008;9(2):137-45.
  • Henriksson M, Epstein D, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, et al. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart 2008;94:717-23. Download from BMJ
  • Hicks L, Gibbs I, Weatherly H, Byford S. Management, leadership and resources in children's homes: what influences outcomes in residential child-care settings? British Journal of Social Work 2008;39(5):828-845. Download from Oxford Journals
  • Hurley J, Pasic D, Lavis J, Culyer AJ, Mustard C, Gnam W. Parallel payers and preferred access: how Canada's workers' compensation boards expedite care for injured and ill workers. HealthcarePapers 2008;8:6-14.
  • Hurley J, Culyer AJ, Gnam W, Lavis J, Mustard C, Pasic D. Response to commentaries. HealthcarePapers 2008;8:52-4.
  • Hurley J, Pasic D, Lavis J, Mustard C, Culyer AJ, Gnam W. Parallel lines do intersect: interactions between the workers' compensation and provincial publicly financed health care systems in Canada. Health Care Policy 2008;3:100-12.
  • Manca A, Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, Taylor RJ, Goeree R, Sculpher MJ. Quality of life, resource consumption and costs of spinal cord simulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain 2008;12:1047-58.
  • Manesh AO, Sheldon TA, Pickett KE, Carr-Hill R. Accuracy of child morbidity data in demographic and health surveys. International Journal of Epidemiology 2008;37:194-200. 
  • Mannion R, Marini G, Street A. Implementing payment by results in the English NHS: changing incentives and the role of information. Journal of Health Organization and Management 2008;22(1):79-88.
  • Marini G, Miraldo M, Jacobs R, Goddard M. Giving greater financial independence to hospitals - does it make a difference? the case of English NHS Trusts. Health Economics 2008;17(6):751-75.
  • Martin S, Rice N, Smith PC. Does health care spending improve health outcomes? Evidence from English programme budgeting data. Journal of Health Economics 2008;27(4):826-42.
  • Mason A. New medicines in primary care: a review of influences on general practitioner prescribing. Journal of Clinical Pharmacy and Therapeutics 2008;33:1-10.
  • Mason ACarr-Hill R, Myers L, Street A. Establishing the economics of engaging communities in health promotion: what is desirable, what is feasible? Critical Public Health 2008;18(3):285-97.
  • Mason ARDrummond M. NHS Reimbursement of new cancer drugs: is NICE getting nastier? (abstract from the ISPOR thirteenth annual international meeting May 3-7 2008). Value in Health 2008;11(3):A11.
  • Mason A, Walker S, Claxton K, Cookson R, Fenwick E, Sculpher MThe GMS quality and outcomes framework (PDF , 238kb) : Are the quality and outcomes framework (QOF) indicators a cost-effective use of NHS resources? In: Quality and Outcomes Framework. Joint executive summary: Reports to the Department of Health from the University of East Anglia and the University of York. 
  • McCabe C, Claxton K, O'Hagan A. Why licensing authorities need to consider the net value of new drugs - addressing the tension between licensing and reimbursement. International Journal of Technology Assessment in Health Care 2008;24:140-5. Download from Cambridge Journals
  • McCabe C, Culyer A, Claxton K. The NICE cost-effectiveness threshold: what it is and what it means. Pharmacoeconomics 2008; 9:733-44.
  • Morris S, Gravelle H. GP supply and obesity. Journal of Health Economics 2008;27(5):1357-67.
  • Olry de Labry Lima A, Sordo del Castillo L, Garcia Mochon L, Epstein D, Bermudez C, Villegas R. Evaluacion economica de la prueba genetica de la poliposis adenomatosa familiar. Rev Esp Enfirm Dig 2008;100(8):470-5.
  • Olsen KR, Street A. The analysis of efficiency among a small number of organisations:how inferences can be improved by exploiting patient-level data. Health Economics 2008;17(6):671-81. Download from Wiley
  • Phillips Z, Claxton K, Palmer S. The half-life of truth? what is the appropriate time horizons for research decisions? Medical Decision Making 2008;28:287-99. Download from Sage Journals Online
  • Reeves D, Kennedy A, Fullwood C, Bower P, Gardner C, Gately C, Lee V, Richardson G, Rogers A. Predicting who will benefit from an expert patients programme self-management course. British Journal of General Practice 2008;58(548):198-203.
  • Richardson G, Kennedy A, Reeves D, Bower P, Lee V, Middleton E, et al. Cost-effectiveness of the expert patient programme (EPP) for patients with chronic conditions. Journal of Epidemiology and Community Health 2008;62:361-367.
  • Rodgers M, McKenna C, Palmer S, et al. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Health Technology Assessment 2008;12(34). Download from HTA
  • Rogers A, Kennedy A, Reeves D, Bower P, Lee V, Gardner C, Gately C, Richardson G. The UK expert patients programme: results and implications from a national evaluation. Medical Journal of Australia 2008;Nov17:189(10 Suppl):S21-4.
  • Ryan M, Griffin S, Chitah B, Walker SA, Mulenga V, Kalolo D, Hawkins N, Sculpher MJ, et al. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. Aids 2008;22:749-57.
  • Sculpher MJ. NICE's 2008 methods guide: sensible consolidation or opportunities missed? Pharmacoeconomics 2008;26:721-4.
  • Sculpher MJ. Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics 2008;26:799-806.
  • Soares M, Dumville JC. Critical appraisal of cost-effectiveness and cost-utility studies in health care. Evidence Based Nursing 2008;11(4):99-102. Download from BMJ
  • Soares M, Dumville JC. Economic evaluation of healthcare technologies using primary research. Evidence Based Nursing  2008;11(3):67-71. Download from BMJ
  • Spiby H and the ELSA team. Improving care at the primary/secondary interface: a trial of community-based support in early labour (ELSA). Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO). November 2008. Download from NIHR
  • Tompa E, Culyer AJ, Dolinschi R. Suggestions for a reference case. In: Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:235-44.
  • Tompa E, Culyer AJ, Dolinschi R, (Eds). Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008.
  • Whalley D, Gravelle H, Sibbald B. Impact of the new general medical services contract on general practitioners' job satisfaction and perceptions of quality of care in the UK. British Journal of General Practice 2008;58:8-14.
  • Zarate V, Kind P, Chuang LH. Hispanic valuation of the EQ-5D health states: A social value set for Latin Americans. Value in Health 2008;11(7):1170-77.

2007

  • Asseburg C, Bravo Vergel Y, Palmer S, Fenwick E, de Belder M, Abrams A, Sculpher M. Assessing the effectiveness of primary angioplasty compared to thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Heart 2007;93:1244-50. Download from BMJ
  • Bansback N, Maetzel A, Drummond MF, Anis A, Marra C, Conway P, Tugwell P, Boers M, Boonen A. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis. The Journal of Rheumatology 2007;34(5):1178-83.
  • Bojke L, Hornby E, Sculpher M; on behalf of the REFLUX Trial Team. A comparison of the cost effectiveness of pharmacotherapy or surgery (Laporoscopic Fundoplication) in the treatment of GORD. Pharmacoeconomics 2007;25(10):829-41.
  • Bravo Vergal Y, Hawkins N, Claxton K, Asseburg C, Palmer S, Woolacoot N, Bruce IN, Sculpher MJ. The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology 2007;46:1729-35. Download from Oxford Journals
  • Bravo Vergel Y, Palmer S, Asseburg C, Fenwick E, De Belder M, Abrams A, Sculpher M. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis. Heart 2007;93:1238-43. Download from BMJ
  • Briggs A, Mihaylova B, Sculpher M, et al. The cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart 2007;93:1081-6.
  • Caraher M, Carr-Hill R. Taxation, public health and macro-social determinants: ‘sin taxes’ or structured approaches. In: Galea S, Editor. Macrosocial Determinants of Population Health 2007:211-32. 
  • Carr-Hill R. Educational services and nomadic groups. In: Dyer C, editor. The education of nomadic peoples: current issues and future prospects. Berghahn Books;2007.
  • Carr-Hill R, Dixon P. Indicators of equality and diversity: patterns of social difference associated with membership of groups identified by the categories of section 75 of the Northern Ireland Act, 2007:2007. 
  • Castelli A, Dawson D, Gravelle HStreet A. Improving the measurement of health system output growth. Health Economics. 2007;16(10):1091-107.
  • Castelli A, Dawson D, Gravelle HJacobs R, Kind P, Loveridge P, Street A, et al. A new approach to measuring health system output growth and productivity National Institute Economic Review 200 (April) 105-117;2007. Download from Sage journals Online
  • Claxton K. OFT,VBP:QED? Health Economics 2007;16:545-58. Download Wiley InterScience
  • Claxton K. The irrelevance of inference: a decision making approach to the stochastic evaluation of health care technologies. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007(0-415-35235-5).
  • Claxton K, Culyer A. Rights, responsibilities and NICE: a rejoinder to Harris. Journal of Medical Ethics 2007;33:462-4. 
  • Colbourn T, Asseburg C, Bojke L, Phillips Z, Claxton K, Ades A, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses  Health Technology Assessment 2007;11(29):1-208.
  • Colbourn T, Asseburg C, Bojke L, Philips Z, Welton N, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: Cost effectiveness and value of information analyses. British Medical Journal 2007;Sept 29;335(7621):655.
  • Cookson R, Dusheiko MHardman G. Socio-economic inequality in small area use of elective total hip replacement in the English NHS in 1991 and 2001. Journal of Health Services Research and Policy 2007;12 suppl.
  • Culyer AJ. NICE misconceptions. The Lancet September 11 2007.
  • Culyer AJ. Equity of what in health care? Why the traditional answers don't help policy - and what to do in the future. HealthcarePapers 2007;8(Sp):12-26.
  • Culyer AJ. Need - an instrumental view. In: Ashcroft R, Dawson A, Draper H, McMillan J, editors. Principles of health care ethics, 2nd Edition. Chichester:Wiley;2007;231-238.
  • Culyer AJ. When and how cancer chemotherapy should be privately funded. Oncology Exchange, 2007;6:47.
  • Culyer AJ. Merit goods and the welfare economics of coercion. In: Ver Eecke W,  editor. Anthology regarding merit goods. The unfinished ethical revolution in economic theory. West Lafayette: Purdue University Press;2007;174-200 (reprinted from Public Finance. 1971;26:546-572).
  • Culyer AJ, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Not so… Journal of Health Service Research and Policy 2007;12:190-191. (letter: reply to G Mooney, J Coast, S Jan, D McIntyre, M Ryan and V Wiseman).
  • Culyer AJ. Resource allocation in health care: Alan Williams’ decision maker, the authority and Pareto. In: Mason A, Towse A, editors. The Ideas and Influence of Alan Williams: Be Reasonable -Do it My Way! Oxford: Radcliffe Publishing; 2007. p. 57-74.
  • Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. Journal of Health Services Research and Policy 2007;12:56-8. 
  • Davies H, Mannion R, Jacobs R, Powell AE, Marshall MN. Does hospital organisational culture influence hospital performance. Medical Care and Research Review 2007;64(1):66-82.
  • Dawson D, Gravelle H, Jacobs R, Martin S, Smith PC. The effects of expanding choice of provider on waiting times: evidence from a policy experiment. Health Economics 2007;16(2):113-28.
  • Drummond M, Mason A. Costs and cost-effectiveness of cancer therapies: a european perspective. J Clin Oncol 2007;25(2):191-195.
  • Drummond MF. Evidence for coverage decisions: the need for a reality check. Value in Health 2007;10(5):321.
  • Drummond MF. NICE: A nightmare worth having? Health Economics, Policy and Law 2007;2(2):203-8.
  • Dusheiko M, Gravelle H, Yu N, Campbell S. The impact of budgets for gatekeeping physicians on patient satisfaction: evidence from fundholding. Journal of Health Economics 2007;26:242-62.
  • Epstein D. The health related quality of life of patients with acute coronary syndrome: a comparison of early intervention versus conservative management. Revista Espanola de Economia de la Salud 2007;6:380-5.
  • Epstein D, Chalabi Z, Claxton KSculpher M. Efficiency, equity and budgetary policies: informing decisions using mathematical programming. Medical Decision Making 2007;27:128-37. Download from Sage Journals Online
  • Fenwick E, Claxton K, Sculpher MJ. Representing uncertainty: the role of cost-effectiveness acceptability curves. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007 (0415-35235-5).
  • Fleurence RL, Iglesias C, Johnson JM. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature. Pharmacoeconomics 2007;25(11):913-33.
  • Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, Herrington SA, Hays RD, Kaplan RM, Ganiats TG, Feeny d, Kind P. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Medical Care 2007;45(12):1162-70.
  • Goeree R, Burke N, O'Reilly D, Manca A , Blackhouse G, Tarride JE. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Current Medical Research and Opinion 2007;23(4):671-82. 
  • Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evalutations: stepping forward to optimal decision rules. Health Economics 2007;16:307-317.
  • Gravelle H, Dusheiko M, Sheaff R, Sargent P, Boaden R, Pickard S, Parker S, Roland M. Impact of case managment (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data. British Medical Journal 2007;334:31-34. 
  • Gravelle H, Dusheiko M, Sheaff R, Sargent P, Boaden R, Pickard S, et al. Impact of case managment (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data. British Medical Journal 2007;334:31.
  • Gravelle H, Hole A. The work hours of general practitioners' workload: survey of English GPs. British Journal of General Practice . 2007;57:96-100.
  • Gravelle H, Siciliani L. Optimal waits and charges in health insurance. February 2007; Department of Economics Discussion Paper 07/02.
  • Griffin SC, Barber JA, Manca A, Sculpher M, Thompson SG, Buxton MJ, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina. British Medical Journal 2007;334(7594):624. Download from BMJ
  • Griffin S, Claxton K, Hawkins N, Sculpher M. Decision models need to be fit for purpose for decision making: response to Caro et al. Value in Health 2007;10(4):319. Download Wiley InterScience
  • Hanratty B, Craig D, Nixon J, Rice S, Christie J, Drummond MF. Are the best available clinical effectiveness data used in economic evaluations of drug therapies? Journal of Health Services Research and Policy 2007;12:(3):138-41
  • Hauck K, Street A. Do targets matter? A comparison of English and Welsh national health priorities. Health Economics 2007;16:275-90.
  • Hicks L, Gibbs I, Weatherly H, Byford S. Managing Children's Homes. Developing effective leadership in small organisations. London: Jessica Kingsley Publications 2007. Details from Jessica Kingsley Publishers
  • Hole AR. A comparison of approaches to estimating confidence intervals for willingness to pay measures. Health Economics 2007;16:827-40.
  • Hole A. Fitting mixed logit models by using maximum simulated likelihood. Stata Journal 2007;7:388-401.
  • Jacobs R, Goddard M. How do performance indicators add up? An examination of composite indicators in public services. Public Money and Management 2007;27(2):103-110.
  • Jacobs R, Goddard M, Smith P. ‌‌‎‌‎ Policy Discussion Briefing, Centre for Health Economics, University of York; 2007.
  • Jacobs R, Goddard M, Smith PC. Are composite indicators a good measure of performance? Laria News, LARIA Newsletter, Local Authorities Research Intelligence Association 2007;83.
  • Jacobs R, Goddard M, Smith PC. Composite measures of performance: should we trust them? Performance Measurement Association Newsletter 2007;6(1):12-14
  • Kennedy A, Reeves D, Bower P, Lee V, Middleton E, Richardson G, et al. The effectiveness and cost effectiveness of a national lay led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. Journal of Epidemiology and Community Health 2007;61:254-61. 
  • Keen J, Deeming C, Moore J, Weatherly H. New labour, equity and public services: a Rawlsian perspective. Policy and Politics. 2007;35(2):197-214.
  • Kind P. Size matters: EQ-5D in transition. Medical Care 2007;45(9):809-11.
  • Manca A, Dumville J, Torgerson DJ, Klaber Moffett JA, Mooney MP, Jackson DA, et al. Randomised trail of two physiotherapy interventions for primary care back and neck pain patients: cost-effectiveness analysis. Rheumatology 2007;46:1495-1501.
  • Manca A, Lambert PC, Sculpher M, Rice N. Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelling. Medical Decision Making 2007;27:471-90. Download from Sage Journals Online
  • Marini G. Non-Keynesian effects of fiscal policy: the role of rational expectations, (In Italian). Rivista Italiana di Economia demografia e Statistica 2007.
  • Marini G, Street A. A transactions costs analysis of changing contractual relations in the English NHS. Health Policy. 2007;83(1):17-26.
  • Marini G, Miraldo M, Jacobs R, Goddard M. Foundation Trusts in the NHS: does more freedom make a difference? Health Policy Matters 2007;13:1-8.
  • Martin S, Rice NJacobs R, Smith PC. The market for elective surgery: Joint estimation of supply and demand. Journal of Health Economics 2007;26(2):263-285.
  • Mason A. The HealthBASKET Project: documenting the benefit basket and evaluating service costs in Europe. In: Curtis L, ed. Unit Costs of Health and Social Care 2007. Canterbury: University of Kent 2007:15-18. Available at http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007_healthbasket.pdf
  • Mason AR, Carr-Hill R, Myers L. Rapid review of the economic evidence for community engagement and community development approaches in interventions or initiatives seeking to address wider determinants of health. Report and evidence tables. Final report for NICE Community Enagagment project; 2007.  
  • Mason A, Towse A (eds). The ideas and influence of Alan Williams. Be reasonable - do it my way!. New York: Radcliffe Publishing, Oxford. November 2007.
  • Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. The effectiveness and cost-effectiveness of respite for caregivers of frail older people: a systematic review. J Am Geriatr Soc . 2007;55(2):290-9.
  • Mason AWeatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. A systematic review of the effectiveness and cost-effectiveness of different models of community-based care for frail older people and their carers. Health Technology Assessment ; April 2007;11(15):1-176. Download from HTA
  • McCabe C, Claxton K , Tsuchiya A, Raftery J. Assessing the economics challenges posed by orphan drugs: a comment on Drummond et al. International Journal of Technology Assessment in Health Care. 2007;23:397-401.
  • McDaid C, Griffin S, Weatherly H. The Continuous Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea-Hypopnoea Syndrome: a Systematic Review and Economic Analysis: Assessment report for the National Institute for Health and Clinical Excellance; September 2007.  
  • Olry de Labry Lima A, Epstein D, Garcia Mochon L, et al. Comparacion de costes y supervivencia en pacientes intervenidos quirurgicamente de cancer colorrectal segun diferentes modelos organizativos. Rev Esp Enfirm Dig. 2007;99(11):643-7.
  • Ossa DF, Briggs A, McIntosh E, Cowell W, Littlewood T, Sculpher M. Recombinant erythropoietin for chemotherapy-related anaemia. Pharmacoeconomics 2007;25:223-37.
  • Preker AS, Xingzhu L, Velenyi EV, Baris E. Public ends, private means: strategic purchasing of health services. Washington D.C: The World Bank; 2007.
  • Robson LS, Clarke J, Cullen K, Bielecky A, Severin C, Bigelow P, Irvin E, Culyer AJ,  Mahood Q. The effectiveness of occupational health and safety management system interventions: A systematic review. Safety Science 2007;45:329-53.
  • Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytical cost-effectiveness models: a suggested framework and example of application. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007 (0415-35235-5).
  • Siciliani L. Optimal contracts for health services in the presence of waiting times and asymmetric information. The BE Journal of Economic Analysis & Policy Contributions 2007;7(1):article 40.
  • Siciliani L, Martin S. An empirical analysis of the impact of choice on waiting times. Health Economics 2007;16(8):763-79.
  • Spilsbury K, Nelson A, Cullum N, Iglesias C, Nixon J, Mason S. Pressure ulcers and their treatment and effects on quality of life: hospital inpatient perspectives. Journal of Advanced Nursing 2007;Mar 57(5):494-504.
  • Street A. Does information technology improve the productivity of the health care system? Revista Espanola de Economia de la Salud. 2007;6(5):282-6. 
  • Street A. Should GPs hold budgets to purchase hospital services? Revista Espanola de Economia de la Salud. 2007;6(2):88-92.
  • Street A. The contribution of ICT to health care system productivity and efficiency: what do we know? Organisation for Economic and Community Development, Paris. March 2007.
  • Street A, Maynard A. Activity Based Financing in England: the Need for continual Refinement of Payment by Results. Health Economics, Policy and Law 2007;2(4):419-27. Download from Cambridge journals‌‌‎
  • Street A, Maynard A. Payment by results (PDF , 41kb)‌‌‎‌‎ : qualified ambition? Health Economics, Policy and Law 2007;2(4):445-8. 
  • Street A, Miraldo M. The impact of the reform of hospital funding in England (PDF , 246kb)‌‌‎‌‎ . Paper presented at: Evaluating Health Policy: New Evidence from administrative Data. University of York 2007.
  • Suresh Punekar Y, Rodriguez-Roisin R, Sculpher M, Jones P, Spencer M. Implications of chronic obstructive pulmonary disease (COPD) on patients health status: a western view Respiratory Medicine 2007;101:661-69. Download from Elsevier
  • Walker S, Palmer S, Sculpher M. The role of NICE technology appraisal in NHS rationing.British Medical Bulletin 2007:1-14.Download from Oxford Journals